Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 19Recruiting 9Unknown 7Terminated 4Active not recruiting 4Not yet recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Cystic Fibrosis 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Mastectomy × Clear all
NCT02326974 2026-04-17

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
164 enrolled 19 charts
Breast

Breast Neoplasms

NCT02624973 2026-02-12

PETREMAC

Haukeland University Hospital

Phase 2 Active not recruiting
200 enrolled
Breast

Breast Neoplasms

NCT04585074 2025-05-15

MARRES

Severance Hospital

Active not recruiting
2,000 enrolled
Breast

Breast Neoplasms, Cystic Fibrosis

NCT06378294 2025-03-20

MACMA

University Hospital A Coruña

Active not recruiting
82 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡